HILLHOUSE INVESTMENT MANAGEMENT, LTD.

Track

Insider profile

Performance

Overall performance
1.6
Performance over holding periods
1.6
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
HILLHOUSE INVESTMENT MANAGEMENT, LTD.'s trades of Arrivent Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-03 2025-12-10
S Sale
40,435 +24.5%
449.36
US$1,011,716 		40,435 +24.5% 449.36 US$1,011,716
2024-02-01 2024-01-30
B Purchase
20,100 +33.1%
320.22
US$4,848,610 		20,100 +33.1% 320.22 US$4,848,610
2021-10-27 2021-10-25
US Enfusion Inc (ENFN)
S Sale
84,450 +17.9%
23.51
US$3,789,388 		84,450 +17.9% 23.51 US$3,789,388